Gretchen Bachman and Christine Fu (USAID); Lisa Parker, Jenifer Chapman, Lisa Marie Albert, Walter Obiero, and Susan Settergren from MEASURE Evaluation. January 2017 Webinar.
OVC_HIVSTAT and Linkages to Care for Strengthened Collection, Analysis, and U...MEASURE Evaluation
This webinar focused on explaining the HIV Risk Assessment cascade and how it is related to OVC_HIVSTAT disaggregates. The presenters also provided guidance for how OVC_HIVSTAT data can be analyzed to enhance program outcomes.
Lessons learned in using process tracing for evaluationMEASURE Evaluation
Access the recording for this Data for Impact (D4I) webinar at https://www.data4impactproject.org/lessons-learned-in-using-process-tracing-for-evaluation/
Evaluation of the Impact of a Social Support Strategy on Treatment OutcomesMEASURE Evaluation
Shared at a data dissemination and data use workshop on the results of the impact evaluation of the Strengthening Tuberculosis Control in Ukraine project. Access another presentation at https://www.slideshare.net/measureevaluation/evaluation-of-the-tbhiv-integration-strategy-on-treatment-outcomes.
Geospatial Analysis: Innovation in GIS for Better Decision MakingMEASURE Evaluation
Discussion led by John Spencer and Mark Janko. This webinar shared new techniques in geospatial analysis and how they have the potential to transform data-informed decision making.
Seven Steps to EnGendering Evaluations of Public Health ProgramsMEASURE Evaluation
Because international development increasingly focuses on gender, evaluators need a better understanding of how to measure and incorporate gender—including its economic, social, and health dimensions—in their evaluations. This interactive training, consisting of this presentation and a tool, will help participants learn to better evaluate programs with gender components. Access the tool at https://www.measureevaluation.org/resources/publications/tl-19-40
Webinar presentation by Susan Pietryzk. Access the webinar recording at http://www.measureevaluation.org/resources/webinars/measuring-impact-qualitatively
Data for Impact hosted a one-hour webinar sharing guidance for using routine data in evaluations. More: https://www.data4impactproject.org/resources/webinars/routine-data-use-in-evaluation-practical-guidance/
Planning the Evaluation
Impact models
Types of inference and choice of design
Defining the indicators and obtaining the data
Carrying out the evaluation
Disseminating evaluation findings
Working in large-scale evaluations
Using case-based methods to assess scalability and sustainability: Lessons fr...Barb Knittel
Overview of the SC4CCM project and end-line evaluation questions focused on scalability and sustainability. Methodological approaches including case selection strategies, mixed method approaches, within-case and cross-case analysis processes. (Sangeeta Mookherji, GWU)
OVC_HIVSTAT and Linkages to Care for Strengthened Collection, Analysis, and U...MEASURE Evaluation
This webinar focused on explaining the HIV Risk Assessment cascade and how it is related to OVC_HIVSTAT disaggregates. The presenters also provided guidance for how OVC_HIVSTAT data can be analyzed to enhance program outcomes.
Lessons learned in using process tracing for evaluationMEASURE Evaluation
Access the recording for this Data for Impact (D4I) webinar at https://www.data4impactproject.org/lessons-learned-in-using-process-tracing-for-evaluation/
Evaluation of the Impact of a Social Support Strategy on Treatment OutcomesMEASURE Evaluation
Shared at a data dissemination and data use workshop on the results of the impact evaluation of the Strengthening Tuberculosis Control in Ukraine project. Access another presentation at https://www.slideshare.net/measureevaluation/evaluation-of-the-tbhiv-integration-strategy-on-treatment-outcomes.
Geospatial Analysis: Innovation in GIS for Better Decision MakingMEASURE Evaluation
Discussion led by John Spencer and Mark Janko. This webinar shared new techniques in geospatial analysis and how they have the potential to transform data-informed decision making.
Seven Steps to EnGendering Evaluations of Public Health ProgramsMEASURE Evaluation
Because international development increasingly focuses on gender, evaluators need a better understanding of how to measure and incorporate gender—including its economic, social, and health dimensions—in their evaluations. This interactive training, consisting of this presentation and a tool, will help participants learn to better evaluate programs with gender components. Access the tool at https://www.measureevaluation.org/resources/publications/tl-19-40
Webinar presentation by Susan Pietryzk. Access the webinar recording at http://www.measureevaluation.org/resources/webinars/measuring-impact-qualitatively
Data for Impact hosted a one-hour webinar sharing guidance for using routine data in evaluations. More: https://www.data4impactproject.org/resources/webinars/routine-data-use-in-evaluation-practical-guidance/
Planning the Evaluation
Impact models
Types of inference and choice of design
Defining the indicators and obtaining the data
Carrying out the evaluation
Disseminating evaluation findings
Working in large-scale evaluations
Using case-based methods to assess scalability and sustainability: Lessons fr...Barb Knittel
Overview of the SC4CCM project and end-line evaluation questions focused on scalability and sustainability. Methodological approaches including case selection strategies, mixed method approaches, within-case and cross-case analysis processes. (Sangeeta Mookherji, GWU)
Impact Evaluation Training with AERC: China Cash Transfer Programme Technical...The Transfer Project
A hypothetical technical proposal for China's conditional cash transfer programme from our impact evaluation training with AERC in Nairobi, Kenya in July 2019.
International Food Policy Research Institute (IFPRI) organized a three days Training Workshop on ‘Monitoring and Evaluation Methods’ on 10-12 March 2014 in New Delhi, India. The workshop is part of an IFAD grant to IFPRI to partner in the Monitoring and Evaluation component of the ongoing projects in the region. The three day workshop is intended to be a collaborative affair between project directors, M & E leaders and M & E experts. As part of the workshop, detailed interaction will take place on the evaluation routines involving sampling, questionnaire development, data collection and management techniques and production of an evaluation report. The workshop is designed to better understand the M & E needs of various projects that are at different stages of implementation. Both the generic issues involved in M & E programs as well as project specific needs will be addressed in the workshop. The objective of the workshop is to come up with a work plan for M & E domains in the IFAD projects and determine the possibilities of collaboration between IFPRI and project leaders.
Organizational Capacity-Building Series - Session 6: Program EvaluationINGENAES
This session describes different kinds of program evaluations, and key evaluation considerations. These presentations are are part of a workshop series that was implemented in Nepal and 2016 as part of the INGENAES initiative.
Using case-based methods to assess scalability and sustainability: Lessons fr...JSI
Overview of the SC4CCM project and end-line evaluation questions focused on scalability and sustainability. Methodological approaches including case selection strategies, mixed method approaches, within-case and cross-case analysis processes. (Sangeeta Mookherji, GWU)
International Food Policy Research Institute (IFPRI) organized a three days Training Workshop on ‘Monitoring and Evaluation Methods’ on 10-12 March 2014 in New Delhi, India. The workshop is part of an IFAD grant to IFPRI to partner in the Monitoring and Evaluation component of the ongoing projects in the region. The three day workshop is intended to be a collaborative affair between project directors, M & E leaders and M & E experts. As part of the workshop, detailed interaction will take place on the evaluation routines involving sampling, questionnaire development, data collection and management techniques and production of an evaluation report. The workshop is designed to better understand the M & E needs of various projects that are at different stages of implementation. Both the generic issues involved in M & E programs as well as project specific needs will be addressed in the workshop. The objective of the workshop is to come up with a work plan for M & E domains in the IFAD projects and determine the possibilities of collaboration between IFPRI and project leaders.
Similar to Collecting the PEPFAR OVC MER Essential Survey Indicators: Frequently Asked Questions (20)
Managing missing values in routinely reported data: One approach from the Dem...MEASURE Evaluation
This Data for Impact webinar was held in December 2020. Access the recording and learn more at https://www.data4impactproject.org/resources/webinars/managing-missing-values-in-routinely-reported-data-one-approach-from-the-democratic-republic-of-the-congo/
This Data for Impact webinar took place October 29, 2020. Learn more at https://www.data4impactproject.org/resources/webinars/use-of-routine-data-for-economic-evaluations/
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Collecting the PEPFAR OVC MER Essential Survey Indicators: Frequently Asked Questions
1. Monitoring, Evaluation, and Reporting (MER) Orphan and
Vulnerable Children Essential Survey Indicators
Gretchen Bachman and
Christine Fu
USAID
Lisa Parker, Jenifer Chapman,
Lisa Marie Albert, Walter
Obiero, and Susan Settergren
MEASURE
Evaluation/Palladium
January 31, 2017
FREQUENTLYASKEDQUESTIONS
2. Outcome indicators measuring household and child
well-being
• Designated as “Essential Survey Indicators” (ESI)
Purpose:
• To obtain snapshot of program outcomes at a point in time
AND
• To assess changes in outcomes among orphans and
vulnerable children (OVC) program beneficiaries over time
The purpose
3. 9 MER Essential Survey Indicators
1. Percent of children whose primary caregiver knows child’s HIV status
2. Percent of children <5 years of age who are undernourished
3. Percent of children too sick to participate in daily activities
4. Percent of children who have a birth certificate
5. Percent of children regularly attending school
6. Percent of children who progressed in school during the last year
7. Percent of children <5 years of age who recently engaged in
stimulating activities with any household member over 15 years of age
8. Percent of caregivers who agree that harsh physical punishment is an
appropriate means of discipline or control in the home or school
9. Percent of households able to access money to pay for unexpected
household expenses
4. MER implementation to date
Data reported into DATIM:
• Uganda
• Zimbabwe
• Swaziland
Data collection completed:
• Namibia
• Nigeria
• Kenya
• Cote d’Ivoire
Upcoming:
• Lesotho
• Rwanda
• Mozambique
• Botswana
• Tanzania
• Haiti
• Malawi
• DRC
6. How will the data be used?
Data will support:
• Strategic portfolio development
• Targeting
• Programming
• Implementation
• Resource allocations
• Provide evidence to the U.S. Congress
• Be triangulated with other relevant OVC
data
7. What types of decisions will be made based on
MER OVC Essential Survey Indicator data?
Example: Education
indicators
• USG Mission
decisions
• Implementing
partner decisions
8. Is a MER OVC ESI survey required for all
OVC projects?
• Requirement for OVC projects with an
annual budget of USD $1 million
• Countries with total HKID funding of less
than USD$1 million per year are not
required
9. How should countries select PEPFAR-funded OVC projects
for an OVC Essential Indicator Survey?
Considerations:
• Agency representation
• Project size, scope, and funding level
• Availability of accurate data project registers
• Timeline of the project
• Budget available for the survey
Not necessary to collect MER OVC ESIs from all OVC
projects in a country
10. Who is responsible for designing, collecting, and reporting
the MER Essential Survey Indicators?
USG Mission
• Responsible for collection of MER ESIs
• Procures data collection services directly—or
through the OVC implementing partner(s)
Data Collection Organization
• Must be external to project service delivery
• Writes survey report and prepares indicators for
reporting and submission
OVC Implementing Partner
• Enters the indicator data into DATIM
11. Do study protocols need to be reviewed
by USG?
Yes, protocols should be submitted to the
USG Mission and the PEPFAR OVC Technical
Working Group - for review prior to IRB
submission
Protocols will be reviewed to ensure that
guidance is being adhered to
12. Is ethical approval required for the collection of the
MER Essential Survey Indicators?
U.S. regulations: Not considered research and
does not require ethical review
However,
1) surveys involve vulnerable populations, and
2) ethics review may be required locally
• If country requires ethics review—recommended to
submit to U.S. ethics board
13. Do all nine Essential Survey Indicators need to
be collected?
• Yes—even if project not implementing
interventions directly linked to outcome
indicator
• Allows for holistic picture of well-being of
project beneficiaries across projects and
countries
14. Have any changes been made to the survey
tool?
Two questions added:
1) Which specific OVC interventions the
household and/or its members have
received
2) When beneficiary was registered with
project and/or how long beneficiary has
been receiving services
15. Is it possible to adapt the survey questions to
better reflect the local context?
The indicators should be administered
exactly as written
Translated questions should be adjusted to
align with local discourse
Recall periods should not be changed
16. Is it possible to add questions?
Questions can be added to obtain
additional information
Balance need for additional information
with extra time and costs
17. When should the MER survey be conducted?
• Should be collected at:
two points in time
two years apart
during the same time of the year
beginning of project
• Need to balance:
sufficient number of beneficiaries enrolled and
beneficiaries having not received more than six
months of services
Do not recommend conducting MER survey for projects
ending in less than two-and-a-half years.
18. Who should be surveyed at Round 1?
• Households
representative of
all registered,
active project
beneficiaries
• Survey not
designed to assess
outcomes among
children in general
population
Photo credit: Lisa Marie Albert
19. How should geographic areas, households, and
children be chosen for the Round 2 survey?
Beneficiary cohorts maintained for at least two
years:
• Cross-section of all active beneficiaries at the time of
Round 2
Graduate beneficiaries in less than two years:
• Cross-section of all active beneficiaries at the time of
Round 1(includes those that have transitioned,
graduated, or exited the project)
20. Should we conduct MER surveys in PEPFAR transition
areas or for projects that are follow-ons?
We do not recommend collecting the ESIs in
PEPFAR transition areas
If MER survey conducted on previous project
within last two years not necessary to conduct
baseline MER survey for new project
• If follow-on project is similar to previous project
21. Is it possible to compare results across
projects?
Advise against comparing indicator results across projects
even within the same country
Comparisons between projects may be misleading
Projects can differ significantly from one another:
• How long project implemented
• Target populations/project eligibility requirements
• Different geographies
22. Is it acceptable to aggregate data from all projects
operating within a geographic region?
We advise against aggregating due to variation
in:
• project implementation
• design
• duration
• contextual factors, and
• beneficiary vulnerability criteria
Data must be project-specific and reflect project
as a whole
23. If improvements over time in the indicators can
we attribute changes to the project?
No comparison group—we cannot attribute
changes in indicators to project
Triangulating the MER survey data with data from:
• routine monitoring
• household vulnerability assessments
• evaluations, and
• case management
Use conceptual framework to help interpret
24. Can the MER OVC ESIs be accurately
captured through an evaluation?
1. Does the evaluation study include a large
enough sample of project beneficiaries?
2. Does the evaluation study include all
geographic areas where the program operates
or is it restricted to a sub-area?
3. Does the evaluation focus on beneficiaries
receiving a specific subset of interventions?
25. What type of information should be included in the
MER Essential Survey Indicator report?
• Study design
• Sampling procedures
• Study population
• Indicator values presented in context
Data interpretation
Conceptual framework
26. Who needs to have a copy of the final MER
Essential Survey Indicator data and reports?
Organization designing and collection the MER data
• Provides study dataset/s in an excel file or csv format
to the USG Mission
• Submits survey report to PEPFAR OVC Technical
Working Group via Christine Fu, USAID’s senior
research and evaluation advisor, at chfu@usaid.gov
Data storage
• At USG mission and on USAID/Washington’s Datahub
repository
Datasets must be de-identified
27. How should the data be entered into
DATIM?
Numerators and denominators should be
entered by age-group and sex
Narrative section should include:
• OVC project interventions
• Beneficiary population
• Study design
• Sampling strategy and sample size
• Etc.
29. How should we select our sample?
Cluster Sampling:
For medium-sized and large projects
30 cluster minimum
Probability proportionate to size recommended
Example: 33 cluster x 15 household design
Simple Random Sampling
For smaller projects
30. Which children in the household should be
included in the survey?
Interview caregiver
about all children
ages 0–17 years
within the
beneficiary
household
Photo credit: Lisa Marie Albert
31. How can we ensure that the sampling frame is
representative of program beneficiaries?
Conduct data quality
assessments
Address any
deficiencies in
record-keeping prior
to implementing
survey and
developing sampling
frame
32. Future resources in development
• Protocol template
• Community Trace and Verify guidance
• Enumerator data collection manual
• Supervisor data collection manual
34. Q&A
USAID
• Gretchen Bachman
• Christine Fu
MEASURE Evaluation/Palladium
• Lisa Parker
• Lisa Marie Albert (OVCimpact.org)
• Jenifer Chapman (Mozambique, Tanzania)
• Walter Obiero (Nigeria, Namibia)
• Susan Settergren (Kenya, Lesotho)
Resource persons:
35. Further questions?
Please contact Christine Fu, USAID senior research
and evaluation advisor, at: chfu@usaid.gov
To reach MEASURE Evaluation send e-mails to
ovcimpact@thepalladiumgroup.com
OVC Impact Website: https://ovcimpact.org/
36. This presentation was produced with the support of the United States Agency for
International Development (USAID) under the terms of MEASURE Evaluation
cooperative agreement AID-OAA-L-14-00004. MEASURE Evaluation is
implemented by the Carolina Population Center, University of North Carolina at
Chapel Hill in partnership with ICF International; John Snow, Inc.; Management
Sciences for Health; Palladium; and Tulane University. Views expressed are not
necessarily those of USAID or the United States government.
www.measureevaluation.org